Skip to content
Home/Companies/MedTech/Bedfont Scientific
Bedfont Scientific

Bedfont Scientific

MedTech·UK·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns Bedfont Scientific?

Bedfont Scientific is a British MedTech company, currently owned by Keensight Capital since 2025.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY
Keensight Capital
Investor
Keensight Capital
Keensight Nova V · 2019 · Buyout

Key facts

HQUK
SectorMedTech
Websitewww.bedfont.com

More from Keensight Nova V

Other portfolio companies in the same fund.

Actico
Actico
Active
TMTGermany· 2025
Dimo Maint
Active
TMTFrance· 2025
Uve
Uve
Active
TMTFrance· 2025
Advancis
Active
TMTFrance· 2024
Ascentry
Active
TMTFrance· 2024
Bedford Consulting
Bedford Consulting
Active
TMTUK· 2024

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns Bedfont Scientific?

Bedfont Scientific is currently owned by Keensight Capital, through Keensight Nova V, since 2025.

When did Keensight Capital acquire Bedfont Scientific?

Keensight Capital acquired Bedfont Scientific in 2025.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue